These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 805019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL.
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Office management of hypertension.
    Moser M.
    Am Fam Physician; 1974 Sep; 10(3):152-8. PubMed ID: 4414894
    [No Abstract] [Full Text] [Related]

  • 5. The reversibility of side effects of guanethidine therapy.
    Bauer GE, Hull RD, Stokes GS, Raftos J.
    Med J Aust; 1973 May 12; 1(19):930-3. PubMed ID: 4736691
    [No Abstract] [Full Text] [Related]

  • 6. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ, Kessler WB, Marks AD, Adlin EV.
    Clin Ther; 1981 May 12; 4(3):175-83. PubMed ID: 7307035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of guanethidine and hydrochlorothiazide in the long-term treatment of essential hypertension.
    Brown WJ, Brown FK.
    Curr Ther Res Clin Exp; 1975 Jun 12; 17(6):544-54. PubMed ID: 808377
    [No Abstract] [Full Text] [Related]

  • 9. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K, Krempler F, Sandhofer F.
    Acta Med Austriaca; 1984 Jun 12; 11(2):49-53. PubMed ID: 6377793
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G, Cuspidi C, Sampieri L, Ambrosioni E, Malini PL, Pessina A, Semplicini A, Cinotti G, Morabito S, Rappelli A.
    J Hum Hypertens; 1990 Feb 12; 4(1):5-11. PubMed ID: 2189027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA, Moskalenko NP.
    Kardiologiia; 1972 Dec 12; 12(12):55-60. PubMed ID: 4661921
    [No Abstract] [Full Text] [Related]

  • 17. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS.
    Clin Ther; 1984 Dec 12; 6(4):451-6. PubMed ID: 6467278
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG.
    JAMA; 1975 Jan 13; 231(2):155-8. PubMed ID: 1088916
    [Abstract] [Full Text] [Related]

  • 19. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN, Gillam PM, Graham BR.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec 13; 4(1):131-40. PubMed ID: 4924319
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.